CSPG4 and melanoma: In the context of melanoma, the team of Sharma et al. used an immunoaffinity approach for the capture of melanoma-derived exosomes from plasma, based on a monoclonal antibody highly specific for the CSPG4 epitope expressed by melanoma cells.